- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lexaria Bioscience Corp (LEXX)
Track today's live Lexaria Bioscience (LEXX) share price, performance and key data on this page with our current NASDAQ:LEXX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Lexaria Bioscience share price on the NASDAQ exchange. Use the dropdown to switch exchange for the LEXX share price, head to our technical summary section, which provides analysis on Lexaria Bioscience share price buy/sell indicators using real-time data (or discuss the Lexaria Bioscience (LEXX) stock price today with other investors in the Lexaria Bioscience NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LEXX share price (ISIN: US52886N4060) to enhance your trading decisions with our free investment tools and resources.
What Is the Lexaria Bioscience Corp Share Price Today?
The Lexaria Bioscience share price today is 0.545.
What Is the Stock Symbol for Lexaria Bioscience Corp
The stock symbol (or 'ticker') for Lexaria Bioscience Corp is "LEXX."
What Stock Exchange Does Lexaria Bioscience Corp Trade On?
Lexaria Bioscience Corp is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience Corp a Good Stock to Buy?
Determining whether Lexaria Bioscience (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LEXX share price (ISIN: US52886N4060) to enhance your trading decisions with our free investment tools and resources.
What Is the Lexaria Bioscience Corp Share Price Today?
The Lexaria Bioscience share price today is 0.545.
What Is the Stock Symbol for Lexaria Bioscience Corp
The stock symbol (or 'ticker') for Lexaria Bioscience Corp is "LEXX."
What Stock Exchange Does Lexaria Bioscience Corp Trade On?
Lexaria Bioscience Corp is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience Corp a Good Stock to Buy?
Determining whether Lexaria Bioscience (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.545
-0.002(-0.38%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.530
0.545
52 wk Range
0.460
1.550
LEXX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5300.545
52 wk Range
0.4601.550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LEXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
3.750
Upside
+588.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.750
(+588.07% Upside)
Earnings
Latest Release
14/04/2026
EPS / Forecast
-0.07 / -0.10
Revenue / Forecast
-- / 100K
Compare LEXX to Peers and Sector
Metrics to compare | LEXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLEXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −0.6x | −0.4x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price/Book | 2.0x | 1.0x | 2.6x | |
Price / LTM Sales | 36.7x | 1.4x | 3.0x | |
Upside (Analyst Target) | - | 78.0% | 56.2% | |
Fair Value Upside | Unlock | 7.7% | 8.9% | Unlock |
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company’s DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lexaria Bioscience (NASDAQ: LEXX) Share Price Today?
The Lexaria Bioscience stock price today is 0.545 USD.
What Stock Exchange Does Lexaria Bioscience (LEXX) Trade On?
Lexaria Bioscience is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Lexaria Bioscience?
The stock symbol (also called a 'ticker') for Lexaria Bioscience is "LEXX."
What Is the Current Lexaria Bioscience Market Capitalisation?
As of today, Lexaria Bioscience (NASDAQ: LEXX) market cap is 13.510M USD.
What Is Lexaria Bioscience's (LEXX) Earnings Per Share (TTM)?
The Lexaria Bioscience EPS is currently -0.456 (Trailing Twelve Months).
When Is the Next Lexaria Bioscience Earnings Date?
Lexaria Bioscience's next earnings report will be released on 17/07/2026.
Is LEXX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lexaria Bioscience moving averages and other technical indicators, the daily buy/sell signal for LEXX stock is Strong Sell.
How Many Times Has Lexaria Bioscience Stock Split?
Lexaria Bioscience has split 3 times. (See the LEXX stock split history page for full effective split date and price information.)
How Many Employees Does Lexaria Bioscience Have?
Lexaria Bioscience has 7 employees, based on their latest Companies House report.
What is the current trading status of Lexaria Bioscience (NASDAQ: LEXX)?
As of 26/06/2026, Lexaria Bioscience (LEXX) is trading at a share price of 0.545 USD, with a previous close of 0.547 USD. The stock has fluctuated within a day range of 0.530 USD to 0.545 USD, while its 52-week range spans from 0.460 USD to 1.550 USD.
What Is Lexaria Bioscience (LEXX) Price Target According to Analysts?
The average 12-month price target for Lexaria Bioscience is 3.750 USD, with a high estimate of 6 USD and a low estimate of 1.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +588.07% Upside potential.
What Is the LEXX Premarket Price?
LEXX's last pre-market stock price is 0.540 USD. The pre-market share volume is 640.000, and the stock has decreased by -0.007, or -1.280%.
What Is the LEXX After Hours Price?
LEXX's last after hours stock price is 0.566 USD, the stock has decreased by 0.019, or 3.470%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.